Amsterdam, E.A., Rendig, S.V., Henderson, G.L. & Mason, D.T. (1981). Depression of myocardial contractile function by propoxyphene and norpropoxyphene. J. Cardiovasc. Pharmacol. , 3, 129-138.
2.
Barraclough, C.J. & Lowe, R.A. (1982). Failure of naloxone to reverse the cardiotoxicity of Distalgesic overdose. Postgrad. Med. J., 58, 667-668.
3.
Chau-Pham, T.I. (1977). Effects of some opiates on the stereospecific binding of 3H-dihydromorphine. Fed. Proc., 36, 993.
4.
Deneau, G.A. & Seevers, M.H. (1954). Drug Addiction and Narcotics, Bulletin, Appendix B.
5.
Due, S.L., Sullivan, H.R. & Mcmahon, R.E. (1976). Propoxyphene: pathways of metabolism in man and laboratory animals. Biomed. Mass Spectrom., 3, 217-225.
Fraser, H.F. & Isbell, H. (1960). Pharmacology and addiction liability of dl- and d-propoxyphene. Bull. Narc., 12, 9-14.
8.
Gruber, C.M., JR, Miller, C.L., Finneran, J. & Chernish, S.M. (1956). The effectiveness of d-propoxyphene hydrochloride and codeine phosphate as determined by two methods of clinical testing for relief of chronic pain. J. Pharmacol. Exp. Ther. , 118, 280-285.
9.
Gruber, C.M., JR, King, E.P., Best, M.M., Schieve, J.F., Elkus, F. & Zmolek, E.J. (1955). Clinical bio-assay of oral analgesic activity of propoxyphene (Lilly), acetylsalicylic acid, and codeine phosphate, and observations on placebo reactions. Arch. Int. Pharmacodyn. Ther., 104,156-166.
10.
Gustafson, A. & Gustafsson, B. (1976). Acute poisoningwithdextropropoxyphene . Acta Med. Scand., 200, 241-248.
11.
Hondeghem, L.M. & Katzung, B.G. (1977). Time and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim. Biophys. Acta , 472, 373-398.
12.
Holland, D.R. & Steinberg, M.I. (1979). Electrophysiologic properties of propoxyphene and norpropoxyphene in canine cardiac conducting tissues in vitro and in vivo. Toxicol. Appl. Pharmacol., 47,123-133.
13.
Hynes, M.D. & Frederickson, R.C.A. (1982). Cross-tolerance studies distinguish morphine- and metkephamid-induced analgesia. Life Sci., 31, 1201-1204.
14.
Hynes, M.D., Lochner, M.A., Bemis, K.G. & Hymson, D.L. (1983). Chronic ethanol alters the receptor binding characteristics of the delta opioid receptor ligand D-Ala2-D-Leu5 enkephalin in mouse brain . Life Sci., 33, 2331-2337.
15.
Hynes, M.D., Smits, S.E., Cantrell, B.E., Nickander, R. & Zimmerman, D.M. (1982) (ed. L. S. Harris). Preclinical pharmacology of Lilly Compound LY150720, a unique 4-phenylpiperidine analgesic. Nat. Inst. Drug Abuse Res. Monogr., 41,119-125.
Kiplinger, G.F. & Nickander, R. (1971). Pharmacologic basis for use of propoxyphene. JAMA, 216, 289-292.
19.
Kosterlitz, H.W. & Watt, A.J. (1968). Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphine (naloxone). Br. J. Pharmacol . Chemother., 33, 266-276.
20.
Kosterlitz, H.W., Paterson, S.J. & Robison, L.E. (1981). Characterization of the K-subtype of the opiate receptor in the guinea-pig brain. Br. J. Pharmacol., 73, 739-949.
21.
Lochner, M.A. & Hynes, M.D. (1984). Dextropropoxyphene exhibits a preference for the delta opioid receptor. Fed. Proc., 43, 965.
22.
Lund-Jacobsen, H. (1978). Cardio-respiratory toxicity of propoxyphene and norpropoxyphene in conscious rabbits. Acta Pharmacol. Toxicol. , 42, 171-178.
23.
McMahon, R.E., SULLIVAN, H. R., DUE, S. L. & MARSHALL, F. J. (1973). The metabolite pattern of d-propoxyphene in man. The use of heavy isotopes in drug disposition studies. Life Sci., 12, 463-474.
24.
McMahon, R.E., Ridolfo, A.S., Hilman, W.C., Wolen, R.L. & Marshall, F.J. (1971). The fate of radiocarbon-labeled propoxyphene in rat, dog, and human. Toxicol. Appl. Pharmacol. , 19, 427-444.
25.
Miller, J.A., JR, Robbins, E.B. & Meyers, D.B. (1963). Antitussive activity of a series of dialkylaminodiphenylbutanol esters. J. Pharm. Sci., 52, 446-451.
26.
Nash, J.F., Bennett, I.F., Bopp, R.J., Brunson, M.K. & Sullivan, H.R. (1975). Quantitation of propoxyphene and its major metabolites in heroin addict plasma after large dose administration of propoxyphene napsylate. J. Pharm. Sci., 64, 429-433.
27.
Nickander, R., Smits, S.E. & Steinberg, M.I. (1977). Propoxyphene and norpropoxyphene: pharmacologic and toxic effects in animals. J. Pharmacol. Exp. Ther., 200, 245-253.
28.
Page, J.G., SULLIVAN, H. R., DUE, S. L. & SLATER, I. H. (1979). Plasma concentrations and electrocardiographic alterations after repetitive administration of propoxyphene to dogs. Toxicol. Appl. Pharmacol. , 50, 505-514.
Pohland, A. & Sullivan, H.R. (1953). Analgesics: esters of 4-dialkylamino-1,2-diphenyl-2-butanols . J. Am. Chem. Soc. , 75, 4458-4461.
31.
Pohland, A. & Sullivan, H.R. (1955). Preparation of alpha-d- and alpha-1,4-dimethylamino-1,2-diphenyl-3-methyl-2-propionyloxybutane. J. Am. Chem. Soc., 77, 3400-3401.
Robbins, E.B. (1955) (sci. ed.). The pharmacologic effects of a new analgesic α-4-dimethylamino - 1,2 - diphenyl - 3 - methyl - 4 - propionyloxybutane . J. Am. Pharm. Assoc., 44, 497-500.
34.
Sorenson, M.B. (1984). Haemodynamic, Electrocardiographic and Cardiometabolic Changes after Overdose of Propoxyphene. An Experimental Study in Pentobarbitone-anaesthetized Pigs, Human Toxicol. 3, Suppl., 53S-59S.
35.
Winger, G., Bertalmio, A. & Woods, J.H. (1982). Discriminative and reinforcing properties of the normetabolites of propoaryphene and meperidine. In Drug Discriminatcon: Applications in CNS Pharmacology, eds F. C. Colpaert & J. L. Slangen, pp. 123-134. Amsterdam: Elsevier Biomedical Press.
36.
Wong, D.T. & Horng, J.S. (1977). Affinities of opiate agonists and antagonists for the enkephalin receptors of rat brain. Res. Comm., 16, 749-752.
37.
Young, A.M., Swain, H.H. & Woods, J.H. (1981). Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in Rhesus monkeys. Psychopharmacology, 74, 329-335.
